| Mrs Dana Mariea Russell, FNP-BC | |
|
1303 Walker School Rd, Maryville, TN 37803-8736 | |
| (865) 724-7378 | |
| Not Available |
| Full Name | Mrs Dana Mariea Russell |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 1303 Walker School Rd, Maryville, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306547476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 33490 (Tennessee) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 33490 (Tennessee) | Primary |
| Entity Name | Dx Mso Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225381148 PECOS PAC ID: 7719131101 Enrollment ID: O20130213000017 |
News Archive
Nearly half of people with symptoms of overactive bladder had to initiate multiple conversations with their doctor before receiving a diagnosis or treatment, according to a national survey of more than 500 people with symptoms of overactive bladder. Furthermore, only 15 percent of those surveyed said their doctors had ever initiated a discussion about overactive bladder symptoms.
Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine on October 6, 2013.
While health care jobs are plentiful, "getting one is hard work," The Associated Press/The News-Sentinel reports. "Many people who have lost jobs to the recession may find a cure for unemployment in the health care field," and the demand for nurses, specialists and technicians is strong
A new method has enabled the natural structure of particularly large and complex enzymes to be revealed. Scientists at Martin Luther University Halle-Wittenberg (MLU) and TU Berlin have published their findings in the journal Cell Reports.
Sermo (http://www.sermo.com), the world's largest online physician's community, today announced a new Sermo Event(TM) Report assessing physician perception of FDA's "refuse to file" (RTF) letter on EMD Serono's Cladribine tablets and its potential impact, if any, on Novartis' oral MS agent in development; Fingolimod. Cladribine is expected to be one of the first oral agents to be approved for the treatment of relapsing and remitting multiple sclerosis.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dana Mariea Russell, FNP-BC 1303 Walker School Rd, Maryville, TN 37803-8736 Ph: (865) 724-7378 | Mrs Dana Mariea Russell, FNP-BC 1303 Walker School Rd, Maryville, TN 37803-8736 Ph: (865) 724-7378 |
News Archive
Nearly half of people with symptoms of overactive bladder had to initiate multiple conversations with their doctor before receiving a diagnosis or treatment, according to a national survey of more than 500 people with symptoms of overactive bladder. Furthermore, only 15 percent of those surveyed said their doctors had ever initiated a discussion about overactive bladder symptoms.
Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine on October 6, 2013.
While health care jobs are plentiful, "getting one is hard work," The Associated Press/The News-Sentinel reports. "Many people who have lost jobs to the recession may find a cure for unemployment in the health care field," and the demand for nurses, specialists and technicians is strong
A new method has enabled the natural structure of particularly large and complex enzymes to be revealed. Scientists at Martin Luther University Halle-Wittenberg (MLU) and TU Berlin have published their findings in the journal Cell Reports.
Sermo (http://www.sermo.com), the world's largest online physician's community, today announced a new Sermo Event(TM) Report assessing physician perception of FDA's "refuse to file" (RTF) letter on EMD Serono's Cladribine tablets and its potential impact, if any, on Novartis' oral MS agent in development; Fingolimod. Cladribine is expected to be one of the first oral agents to be approved for the treatment of relapsing and remitting multiple sclerosis.
› Verified 4 days ago